Cargando…

Does older age justify chlorambucil control arms for chronic lymphocytic leukemia clinical trials: a SEER-Medicare analysis

Detalles Bibliográficos
Autores principales: Diamond, Akiva, Vu, Long, Bensken, Wyatt P., Koroukian, Siran M., Caimi, Paolo F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317827/
https://www.ncbi.nlm.nih.gov/pubmed/37221284
http://dx.doi.org/10.1038/s41375-023-01915-y
_version_ 1785067910844121088
author Diamond, Akiva
Vu, Long
Bensken, Wyatt P.
Koroukian, Siran M.
Caimi, Paolo F.
author_facet Diamond, Akiva
Vu, Long
Bensken, Wyatt P.
Koroukian, Siran M.
Caimi, Paolo F.
author_sort Diamond, Akiva
collection PubMed
description
format Online
Article
Text
id pubmed-10317827
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-103178272023-07-05 Does older age justify chlorambucil control arms for chronic lymphocytic leukemia clinical trials: a SEER-Medicare analysis Diamond, Akiva Vu, Long Bensken, Wyatt P. Koroukian, Siran M. Caimi, Paolo F. Leukemia Letter Nature Publishing Group UK 2023-05-23 2023 /pmc/articles/PMC10317827/ /pubmed/37221284 http://dx.doi.org/10.1038/s41375-023-01915-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter
Diamond, Akiva
Vu, Long
Bensken, Wyatt P.
Koroukian, Siran M.
Caimi, Paolo F.
Does older age justify chlorambucil control arms for chronic lymphocytic leukemia clinical trials: a SEER-Medicare analysis
title Does older age justify chlorambucil control arms for chronic lymphocytic leukemia clinical trials: a SEER-Medicare analysis
title_full Does older age justify chlorambucil control arms for chronic lymphocytic leukemia clinical trials: a SEER-Medicare analysis
title_fullStr Does older age justify chlorambucil control arms for chronic lymphocytic leukemia clinical trials: a SEER-Medicare analysis
title_full_unstemmed Does older age justify chlorambucil control arms for chronic lymphocytic leukemia clinical trials: a SEER-Medicare analysis
title_short Does older age justify chlorambucil control arms for chronic lymphocytic leukemia clinical trials: a SEER-Medicare analysis
title_sort does older age justify chlorambucil control arms for chronic lymphocytic leukemia clinical trials: a seer-medicare analysis
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317827/
https://www.ncbi.nlm.nih.gov/pubmed/37221284
http://dx.doi.org/10.1038/s41375-023-01915-y
work_keys_str_mv AT diamondakiva doesolderagejustifychlorambucilcontrolarmsforchroniclymphocyticleukemiaclinicaltrialsaseermedicareanalysis
AT vulong doesolderagejustifychlorambucilcontrolarmsforchroniclymphocyticleukemiaclinicaltrialsaseermedicareanalysis
AT benskenwyattp doesolderagejustifychlorambucilcontrolarmsforchroniclymphocyticleukemiaclinicaltrialsaseermedicareanalysis
AT koroukiansiranm doesolderagejustifychlorambucilcontrolarmsforchroniclymphocyticleukemiaclinicaltrialsaseermedicareanalysis
AT caimipaolof doesolderagejustifychlorambucilcontrolarmsforchroniclymphocyticleukemiaclinicaltrialsaseermedicareanalysis